Utilize este identificador para referenciar este registo: http://hdl.handle.net/10362/99607
Registo completo
Campo DCValorIdioma
dc.contributor.authorMacHado, Ausenda-
dc.contributor.authorKislaya, Irina-
dc.contributor.authorLarrauri, Amparo-
dc.contributor.authorMatias Dias, Carlos-
dc.contributor.authorNunes, Baltazar-
dc.date.accessioned2020-06-19T01:13:29Z-
dc.date.available2020-06-19T01:13:29Z-
dc.date.issued2019-12-16-
dc.identifier.otherPURE: 18642640-
dc.identifier.otherPURE UUID: 362ddc47-51a8-4ea6-b5eb-eb33869f820f-
dc.identifier.otherScopus: 85076680558-
dc.identifier.otherPubMed: 31842831-
dc.identifier.otherWOS: 000511643500012-
dc.identifier.otherPubMedCentral: PMC6916191-
dc.identifier.urihttp://hdl.handle.net/10362/99607-
dc.description.abstractBackground: All aged individuals with a chronic condition and those with 65 and more years are at increased risk of severe influenza post-infection complications. There is limited research on cases averted by the yearly vaccination programs in high-risk individuals. The objective was to estimate the impact of trivalent seasonal influenza vaccination on averted hospitalizations and death among the high-risk population in Portugal. Methods: The impact of trivalent seasonal influenza vaccination was estimated using vaccine coverage, vaccine effectiveness and the number of influenza-related hospitalizations and deaths. The number of averted events (NAE), prevented fraction (PF) and number needed to vaccinate (NVN) were estimated for seasons 2014/15 to 2016/17. Results: The vaccination strategy averted on average approximately 1833 hospitalizations and 383 deaths per season. Highest NAE was observed in the ≥65 years population (85% of hospitalizations and 95% deaths) and in the 2016/17 season (1957 hospitalizations and 439 deaths). On average, seasonal vaccination prevented 21% of hospitalizations in the population aged 65 and more, and 18.5% in the population with chronic conditions. The vaccination also prevented 29% and 19.5% of deaths in each group of the high-risk population. It would be needed to vaccinate 3360 high-risk individuals, to prevent one hospitalization and 60,471 high-risk individuals to prevent one death. Conclusion: The yearly influenza vaccination campaigns had a sustained positive benefit for the high-risk population, reducing hospitalizations and deaths. These results can support public health plans toward increased vaccine coverage in high-risk groups.en
dc.language.isoeng-
dc.rightsopenAccess-
dc.subjectPublic Health, Environmental and Occupational Health-
dc.subjectSDG 3 - Good Health and Well-being-
dc.titleImpact of national influenza vaccination strategy in severe influenza outcomes among the high-risk Portuguese population-
dc.typearticle-
degois.publication.issue1-
degois.publication.titleBMC Public Health-
degois.publication.volume19-
dc.peerreviewedyes-
dc.identifier.doihttps://doi.org/10.1186/s12889-019-7958-8-
dc.description.versionpublishersversion-
dc.description.versionpublished-
dc.contributor.institutionCentro de Investigação em Saúde Pública (CISP/PHRC)-
dc.contributor.institutionEscola Nacional de Saúde Pública (ENSP)-
Aparece nas colecções:Home collection (ENSP)

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Machado_BMC_Pub_Hea_2019_19_1690.pdf565,2 kBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.